NCT00339768View on ClinicalTrials.gov

A Randomized Multi-Intervention Trial to Inhibit Precancerous Gastric Lesions in Lingu, Shandong Province

PHASE3CompletedINTERVENTIONAL
Enrollment

3,411

Participants

Timeline

Start Date

July 1, 1995

Primary Completion Date

June 10, 1996

Study Completion Date

June 10, 1996

Conditions
Precancerous Gastric Lesions
Interventions
DRUG

Amoxicillin/omeprazole

To treat Helicobacter pylori infections. 2 week course of amoxicillin 1gm bid, omeprazole 20mg bid. This factorial trial also investigated a supplement of vitamin C, vitamin E and selenium and a garlic supplement.

Trial Locations (1)

Unknown

Beijing Institute for Cancer Research, Beijing

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00339768 - A Randomized Multi-Intervention Trial to Inhibit Precancerous Gastric Lesions in Lingu, Shandong Province | Biotech Hunter | Biotech Hunter